Changes to Average Survival of Patients With Amyotrophic Lateral Sclerosis (1995–2018)

医学 肌萎缩侧索硬化 利鲁唑 比例危险模型 危险系数 纪元(天文学) 生存分析 队列 人口 儿科 多元分析 内科学 置信区间 疾病 星星 物理 环境卫生 天文
作者
Rosario Vasta,Filippo De Mattei,Salvatore Tafaro,Antonio Canosa,Umberto Manera,Maurizio Grassano,Francesca Palumbo,Sara Cabras,Enrico Matteoni,Francesca Di Pede,Grazia Zocco,Giorgio Pellegrino,Emilio Minerva,Daniela Pascariu,Barbara Iazzolino,Stefano Callegaro,Giuseppe Fuda,Paolina Salamone,Fabiola De Marchi,Letizia Mazzini
出处
期刊:Neurology [Lippincott Williams & Wilkins]
卷期号:104 (8) 被引量:1
标识
DOI:10.1212/wnl.0000000000213467
摘要

The average survival of patients with amyotrophic lateral sclerosis (ALS) ranges from 2 to 5 years from symptom onset. However, it remains unclear whether this estimate has improved over time. The objective of this study was to analyze the survival trend of a large population-based cohort of patients with ALS over a 24-year period. Patients from the Piemonte and Valle d'Aosta registry for ALS (PARALS) were categorized into the first (1995-2002), second (2003-2010), or third (2011-2018) epoch based on their diagnosis date. Survival was defined as the time from diagnosis to death, tracheostomy, or censoring date. A Cox proportional hazard model was developed with diagnosis epoch as the primary variable of interest, adjusted for sex, site of onset, age at onset, diagnostic delay, forced vital capacity at diagnosis, Δbody mass index from onset to diagnosis, noninvasive mechanical ventilation use, gastrostomy use, and site of follow-up. A subset analysis comparing the 2007-2012 and 2013-2018 cohorts was conducted, incorporating riluzole prescription, genetics, and preslope category as additional covariates. A total of 3,134 patients were included, evenly distributed across the 3 epochs (990, 1,023, and 1,121, respectively). The median survival remained stable during the first and second epoch (18.6 months vs 18.3 months) but improved during the third epoch (20.1 months; p = 0.0041), with a hazard ratio (HR) of 0.76 (95% CI 0.67-0.87, p = 0.00003). In the subset analysis, the most recent epoch (2013-2018) showed a continued survival advantage (HR 0.77, 95% CI 0.65-0.90). Of interest, the survival benefit was only evident among intermediate progressors (HR 0.60, 95% CI 0.45-0.80). In the PARALS, ALS survival increased over time. In a subset analysis, the beneficial effect of the epoch was only evident among intermediate progressors. The improvement in multidisciplinary care provided by tertiary centers may be one possible explanation for this finding, although further dedicated studies are needed to confirm this hypothesis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
量子星尘发布了新的文献求助10
2秒前
2秒前
zhangxin完成签到,获得积分10
3秒前
Xin完成签到,获得积分10
4秒前
叶染发布了新的文献求助10
4秒前
4秒前
江北第一深情完成签到,获得积分20
5秒前
梦想or现实完成签到,获得积分10
6秒前
我是老大应助zjujirenjie采纳,获得50
6秒前
halo发布了新的文献求助10
7秒前
千早爱音完成签到,获得积分10
7秒前
7秒前
meizijiu发布了新的文献求助10
7秒前
77777发布了新的文献求助20
7秒前
樊F_1完成签到,获得积分10
8秒前
Bgsister发布了新的文献求助10
8秒前
9秒前
天天呼的海角完成签到,获得积分10
9秒前
9秒前
Xin发布了新的文献求助10
10秒前
薄荷味的猫完成签到,获得积分10
10秒前
可靠尔曼完成签到,获得积分20
11秒前
Charon完成签到,获得积分20
13秒前
科研通AI2S应助樊F_1采纳,获得10
13秒前
量子星尘发布了新的文献求助10
15秒前
可靠尔曼发布了新的文献求助30
15秒前
ZLWF发布了新的文献求助10
17秒前
ht完成签到,获得积分10
17秒前
19秒前
思源应助但是采纳,获得10
19秒前
香菜完成签到,获得积分10
20秒前
巴啦啦能量完成签到 ,获得积分10
22秒前
JamesPei应助ht采纳,获得10
22秒前
的法国队完成签到,获得积分10
27秒前
27秒前
陨落星辰完成签到 ,获得积分10
27秒前
华仔应助江北第一深情采纳,获得10
27秒前
斯文的斩完成签到,获得积分10
32秒前
33秒前
高分求助中
(禁止应助)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Plutonium Handbook 4000
International Code of Nomenclature for algae, fungi, and plants (Madrid Code) (Regnum Vegetabile) 1500
Building Quantum Computers 1000
Robot-supported joining of reinforcement textiles with one-sided sewing heads 900
Principles of Plasma Discharges and Materials Processing,3rd Edition 500
Atlas of Quartz Sand Surface Textures 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4212563
求助须知:如何正确求助?哪些是违规求助? 3746793
关于积分的说明 11789088
捐赠科研通 3414476
什么是DOI,文献DOI怎么找? 1873603
邀请新用户注册赠送积分活动 928097
科研通“疑难数据库(出版商)”最低求助积分说明 837370